TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
Binding of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to the plasma membrane TRAIL-R1/-R2 selectively kills tumor cells. This discovery led to evaluation of TRAIL-R1/-R2 as targets for anti-cancer therapy, yet the corresponding clinical trials were disappointing. Meanwhile, it e...
Main Authors: | Ufuk Mert, Alshaimaa Adawy, Elisabeth Scharff, Pierre Teichmann, Anna Willms, Verena Haselmann, Cynthia Colmorgen, Johannes Lemke, Silvia von Karstedt, Jürgen Fritsch, Anna Trauzold |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1167 |
Similar Items
-
Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
by: Anna-Laura Kretz, et al.
Published: (2018-03-01) -
Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 – markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics
by: Aleksandra Mielczarek-Palacz, et al.
Published: (2015-11-01) -
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
by: Anna-Christina Rambow, et al.
Published: (2022-09-01) -
Urban trails : a preliminary list of trails and sources/
by: 409605 Goodey, Brian
Published: (1974) -
TRAILblazing Strategies for Cancer Treatment
by: Anna-Laura Kretz, et al.
Published: (2019-03-01)